Adverse effects of carbamazepine monotherapy among patients in Nigeria: A pilot study and implications

Adedunni Olusanya, Olayinka Ogunleye, Brian Godman*, Joseph Fadare, Mustafa Danesi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


Aim: Antiepileptic drugs do cause adverse effects, affecting patients' quality of life, adherence and seizures. Consequently, there is a need to study this among Nigerian patients. Methods: Descriptive cross-sectional study assessing the extent of adverse effects with carbamazepine monotherapy and potential factors. Results: 54 patients (64.3%) reported no adverse effects, while 30 did. The most common adverse effects were memory problems followed by headaches, restlessness, tiredness and depression. Adverse effects were significantly higher in females, with females with low educational levels having significantly higher rates. Dose, co-medications, seizure control and comorbid conditions did not significantly affect adverse effects. Conclusion: Perception of adverse effects was common in patients on carbamazepine monotherapy, more common in women than men. Educational status was important in women.

Original languageEnglish
Pages (from-to)33-42
Number of pages10
JournalJournal of Comparative Effectiveness Research
Issue number1
Publication statusPublished - Jan 2017
Externally publishedYes


  • Adverse events
  • Carbamazepine
  • Epilepsy
  • Nigeria


Dive into the research topics of 'Adverse effects of carbamazepine monotherapy among patients in Nigeria: A pilot study and implications'. Together they form a unique fingerprint.

Cite this